iRhythm Holdings (IRTC) Research & Development (2015 - 2026)
iRhythm Holdings' (IRTC) quarterly Research & Development came in at $21.4 million in Q1 2026, down 0.75% year-on-year from $21.5 million in Q1 2025, and up 1.48% on a QoQ basis from $21.0 million in Q4 2025.
iRhythm Holdings (IRTC) Research & Development (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has 12 years of Research & Development data on file, last reported at $21.4 million in Q1 2026.
- On a quarterly basis, Research & Development fell 0.75% year-over-year to $21.4 million in Q1 2026; TTM through Mar 2026 was $84.4 million, a 11.14% increase from a year earlier, with the FY2025 full-year figure at $84.6 million, up 18.4% from the prior year.
- Research & Development for Q1 2026 stood at $21.4 million, up from $21.0 million in the prior quarter.
- Over the last five years, Research & Development for IRTC reached as high as $21.5 million in Q1 2025 and fell as low as $10.5 million in Q1 2022.
- Historically, Research & Development has averaged $16.7 million across 5 years, with a median of $16.3 million in 2023.
- On a YoY basis, Research & Development climbed as much as 43.96% in 2024 and fell as far as 3.77% in 2024.
- Year by year, Research & Development stood at $12.7 million in 2022, then climbed by 21.63% to $15.4 million in 2023, then rose by 23.77% to $19.1 million in 2024, then advanced by 10.3% to $21.0 million in 2025, then advanced by 1.48% to $21.4 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $21.4 million in Q1 2026, $21.0 million in Q4 2025, and $21.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | iRhythm Holdings | 3.50 Bn | 2.95 Bn | 141.35 Mn | 21.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.36 Mn |
| Dec 31, 2025 | 21.05 Mn |
| Sep 30, 2025 | 21.03 Mn |
| Jun 30, 2025 | 21.01 Mn |
| Mar 31, 2025 | 21.52 Mn |
| Dec 31, 2024 | 19.08 Mn |
| Sep 30, 2024 | 15.69 Mn |
| Jun 30, 2024 | 19.69 Mn |
| Mar 31, 2024 | 16.99 Mn |
| Dec 31, 2023 | 15.42 Mn |
| Sep 30, 2023 | 16.31 Mn |
| Jun 30, 2023 | 13.68 Mn |
| Mar 31, 2023 | 14.84 Mn |
| Dec 31, 2022 | 12.68 Mn |
| Sep 30, 2022 | 11.45 Mn |
| Jun 30, 2022 | 11.95 Mn |
| Mar 31, 2022 | 10.54 Mn |
| Dec 31, 2021 | 11.87 Mn |
| Sep 30, 2021 | 8.69 Mn |
| Jun 30, 2021 | 9.61 Mn |